Smith L, Litman P, Liedtke CM

Mice deficient in NKCC1 have been generated by targeted disruption of the gene encoding NKCC1 involving the carboxyl terminus (CT-NKCC1), but not the amino terminus. We hypothesize that resulting physiological defects are due to loss of proteins interacting with CT-NKCC1. Using a yeast two hybrid approach, adaptor protein COMMD1 was ...

Read More

found to bind to CT-NKCC1 (aa 1040-1212). Binding was verified in a yeast independent system using GST-COMMD1 and myc-CT-NKCC1. Truncated COMMD1 and CT-NKCC1 peptides were used in binding assays to identify the site of interaction. The results demonstrate concentration dependent binding of COMMD1 (aa 1-47) to CT-NKCC1 (aa 1040-1134). Endogenous COMMD1 was detected in pulldowns using recombinant FLAG-CT-NKCC1; this co-pull-down was blocked by COMMD1 (aa 1-47). CT-NKCC1 (aa 1040-1137) decreased basolateral membrane expression of NKCC1 and COMMD1 (aa 1-47) increased NKCC1 membrane expression. Downregulation of COMMD1 using silencing RNA led to a transient loss of endogenous COMMD1, but did not affect activation of NKCC1 by hyperosmotic sucrose. Hyperosmolarity caused a transient increase in NKCC1 membrane expression, indicating regulated trafficking of NKCC1; downregulation of COMMD1 using siRNA reduced baseline (unstimulated) NKCC1 expression and blunted a transient elevation in NKCC1 membrane expression caused by hyperosmolarity. Constitutive downregulation of COMMD1 in HT29 engineered cells exhibited loss of COMMD1 and decreased NKCC1 membrane expression with no effect on activation of NKCC1. Loss of COMMD1 in Calu-3 cells and in HT29 cells led to reduced ubiquinated NKCC1. The results indicate a role for COMMD1 in the regulation of NKCC1 membrane expression and ubiquitination.

Date: Mar. 20, 2013

View in: Pubmed Google Scholar

154441